3 Year Absolute Returns
88.52% ↑
NAV (₹) on 18 Dec 2025
419.23
1 Day NAV Change
-0.27%
Risk Level
Very High Risk
Rating
-
SBI Healthcare Opportunities Fund is a Equity mutual fund categorized under Sector, offered by SBI Funds Management Ltd.. Launched on 14 Jul 1999, investors can start with a minimum SIP of ₹100 or a ... Read more
AUM
₹ 4,130.76 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 60.97% |
| Hospitals & Medical Services | 23.31% |
| Foreign Securities | 4.81% |
| Treps/Reverse Repo | 3.99% |
| Chemicals - Speciality | 3.90% |
| Medical Equipment & Accessories | 3.10% |
| Others - Not Mentioned | 0.08% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 12.73% | ₹ 469.73 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 7.39% | ₹ 272.56 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 6.40% | ₹ 236.29 | Hospitals & Medical Services |
| Lonza Group | 4.81% | ₹ 177.55 | Others |
| Cipla Ltd. | 4.77% | ₹ 175.88 | Pharmaceuticals |
| Lupin Ltd. | 4.46% | ₹ 164.45 | Pharmaceuticals |
| TREPS | 3.99% | ₹ 147.23 | Others |
| Mankind Pharma Ltd. | 3.75% | ₹ 138.19 | Pharmaceuticals |
| Krishna Institute of Medical Sciences Ltd. | 3.34% | ₹ 123.17 | Hospitals & Medical Services |
| Fortis Healthcare Ltd. | 3.22% | ₹ 118.66 | Hospitals & Medical Services |
| Ami Organics Ltd. | 3.19% | ₹ 117.63 | Pharmaceuticals |
| Aster DM Healthcare Ltd. | 3.18% | ₹ 117.45 | Hospitals & Medical Services |
| Jupiter Life Line Hospitals Ltd. | 3.18% | ₹ 117.18 | Hospitals & Medical Services |
| Polymedicure Ltd. | 3.10% | ₹ 114.41 | Medical Equipment & Accessories |
| Abbott India Ltd. | 2.97% | ₹ 109.64 | Pharmaceuticals |
| Aether Industries Ltd. | 2.83% | ₹ 104.32 | Chemicals - Speciality |
| Alkem Laboratories Ltd. | 2.76% | ₹ 101.97 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 2.58% | ₹ 95.24 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 2.49% | ₹ 91.82 | Pharmaceuticals |
| Laurus Labs Ltd. | 2.48% | ₹ 91.44 | Pharmaceuticals |
| Rainbow Children's Medicare Ltd. | 2.43% | ₹ 89.76 | Hospitals & Medical Services |
| Gland Pharma Ltd. | 2.33% | ₹ 85.78 | Pharmaceuticals |
| Concord Biotech Ltd. | 1.90% | ₹ 69.94 | Pharmaceuticals |
| Biocon Ltd. | 1.82% | ₹ 67.17 | Pharmaceuticals |
| Vijaya Diagnostic Centre Ltd. | 1.56% | ₹ 57.38 | Hospitals & Medical Services |
| Cohance Lifesciences Ltd. | 1.53% | ₹ 56.58 | Pharmaceuticals |
| Pfizer Ltd. | 1.52% | ₹ 56.13 | Pharmaceuticals |
| Akums Drugs & Pharmaceuticals Ltd. | 1.24% | ₹ 45.71 | Pharmaceuticals |
| Sanofi Consumer Healthcare India Ltd. | 1.07% | ₹ 39.51 | Chemicals - Speciality |
| Gufic Biosciences Ltd. | 1.06% | ₹ 39.10 | Pharmaceuticals |
| 182 DAY T-BILL 05.06.25 | 0.08% | ₹ 3 | Others - Not Mentioned |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 4.22% | -1.96% | 18.27% | 23.53% |
| Category returns | 12.61% | 0.69% | 15.54% | 26.16% |
To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes ... Read more
What is the current NAV of SBI Healthcare Opportunities Fund Regular Growth?
The current Net Asset Value (NAV) of SBI Healthcare Opportunities Fund Regular Growth is ₹419.23 as of 18 Dec 2025. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of SBI Healthcare Opportunities Fund Regular Growth?
The Assets Under Management (AUM) of SBI Healthcare Opportunities Fund Regular Growth is ₹4,130.76 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of SBI Healthcare Opportunities Fund Regular Growth?
SBI Healthcare Opportunities Fund Regular Growth has delivered returns of -1.96% (1 Year), 23.53% (3 Year), 16.61% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of SBI Healthcare Opportunities Fund Regular Growth?
SBI Healthcare Opportunities Fund Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for SBI Healthcare Opportunities Fund Regular Growth?
The minimum lumpsum investment required for SBI Healthcare Opportunities Fund Regular Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article